The speed at which a cell produces proteins is a decisive factor in determining whether it divides, specializes or retains ...

New perfusion technologies and AI-driven controls are accelerating adoption across commercial biologics manufacturing.

Cellular and gene therapies have become established treatment options for hematological diseases, including rare and aggressive neoplasms. The clinical ...

SpudCell is exciting scientists because it appears to bring several features of life together in one system. The researchers describe it as capable of feeding, growth, genome replication, genetically ...

FUJIFILM Biotechnologies (Fujifilm), a world-leading contract development and manufacturing organization (CDMO) for biologics ...